These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7507578)

  • 1. Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice.
    Fuller RW; Snoddy HD
    Neuropharmacology; 1993 Oct; 32(10):995-9. PubMed ID: 7507578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo.
    Fuller RW; Snoddy HD; Krushinski JH; Robertson DW
    Neuropharmacology; 1992 Oct; 31(10):997-1000. PubMed ID: 1279447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo.
    Fuller RW; Hemrick-Luecke SK; Littlefield ES; Audia JE
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):135-49. PubMed ID: 7535937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of central serotonergic pathways in nefopam-induced antinociception.
    Hunskaar S; Fasmer OB; Broch OJ; Hole K
    Eur J Pharmacol; 1987 Jun; 138(1):77-82. PubMed ID: 2442003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.
    Fuller RW; Perry KW; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):793-803. PubMed ID: 1151729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1986 Feb; 24(2):281-4. PubMed ID: 3485293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
    Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats.
    Henderson MG; Fuller RW
    Brain Res; 1992 Oct; 594(2):323-6. PubMed ID: 1280529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyproheptadine antagonism of p-chloroamphetamine hypothermia in mice.
    Burke DH; Ryan RP
    Eur J Pharmacol; 1986 Sep; 129(1-2):195-8. PubMed ID: 2429848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):457-65. PubMed ID: 705024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.
    Andrews AM; Murphy DL
    Eur J Pharmacol; 1993 Dec; 250(2):215-21. PubMed ID: 8112382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine.
    Fuller RW; Perry KW; Molloy BB
    Eur J Pharmacol; 1975 Aug; 33(1):119-24. PubMed ID: 126166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
    Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
    Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors.
    Fuller RW; Snoddy HD; Molloy BB
    Psychopharmacol Commun; 1975; 1(5):455-64. PubMed ID: 1228825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of catecholamines and serotonin receptor subtypes in nefopam-induced antinociception.
    Girard P; Coppé MC; Verniers D; Pansart Y; Gillardin JM
    Pharmacol Res; 2006 Sep; 54(3):195-202. PubMed ID: 16750379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of the involvement of dopamine in the analgesic effect of nefopam.
    Esposito E; Romandini S; Merlo-Pich E; Mennini T; Samanin R
    Eur J Pharmacol; 1986 Sep; 128(3):157-64. PubMed ID: 3098570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers.
    Fuller RW; Snoddy HD
    Biochem Pharmacol; 1993 Jun; 45(11):2355-8. PubMed ID: 8517878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.